In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, and in continuation of the intimation of investor meeting sent earlier vide letter dated 5th March, 2018 Eris Lifesciences has informed that analyst meet will be held on March 6 2018.
The above information is a part of company’s filings submitted to BSE.